Amgen’s stock slides 7.8% premarket after weight-loss drug data lags analyst expectations

By MarketWatch | Created at 2024-11-26 12:51:34 | Updated at 2024-11-26 15:16:22 2 hours ago
Truth

Please enable JS and disable any ad blocker

Read Entire Article